INTRODUCTION
Many studies have shown that the extracellular-signal regulated kinase (ERK) is important for regulation of neuronal function, particularly playing a role in the regulation of synaptic plasticity and long-term memory formation (3, 13, 14, 30, 46, 48) . Considerable evidence is accumulating that ERK activation plays a role in the regulation of postsynaptic excitability, specifically operating in the context of synaptic plasticity (40, 46, 48) . One potential mechanism of this regulation by ERK is indirect, through long-term modulation of cell properties through the control of gene transcription and regulation of channel gene expression (9) . Another possible mechanism for ERK to modulate neuronal excitability is through direct regulation of membrane ion channels that regulate the membrane potential and thereby intrinsic membrane properties.
In our recent studies we have focused on regulation of ion channels by ERK because modulation of excitability may be a critical factor that ultimately controls the induction of long-lasting changes in synaptic strength. One possible direct target of ERK is the K 4 activation (21, 22, 25, 47, 51 ). This ERK modulation of A-type current amplitude can enhance the peak amplitude of back-propagating action potentials in the dendrites (22, 51) and thereby enhance the depolarization seen at synapses. Via this mechanism ERK can ultimately, albeit indirectly, control voltage-dependent NMDA receptor activation.
There is now good evidence that Kv4.2 is the channel-forming primary subunit that underlies this transient A-type current characterized in pyramidal neurons of the hippocampus, as well as in other brain areas and in cardiac myocytes (17-19, 39, 41, 50) .
Studies show that Kv4.2 is localized to the pyramidal cell dendrites (29, 37, 42) .
Furthermore, physiological studies demonstrate that the pharmacological and kinetic properties of Kv4.2-encoded currents in expression systems are similar to the transient outward currents in dendrites (8, 23, 34, 36) . In addition, Kv4.2-encoded currents become even more similar in their characteristics compared to the endogenous A-type current when Kv4.2 is coexpressed with other interacting subunits such as KChIPs (2, 24, 33) as well as DPPX (27, 31) . Finally, preliminary studies indicate that Kv4.2 knock-out animals show a greatly reduced dendritic A-type current in pyramidal cell dendrites (50).
In prior studies we have shown that the cytoplasmic carboxy-terminus of Kv4.2 is phosphorylated by the ERK subtype of the mitogen activated protein kinases (MAPKs) (1) .
In these earlier studies we identified three ERK/MAPK phosphorylation sites at amino acid residues T602, T607 and S616. In the present studies we tested the hypothesis that ERK regulates the Kv4.2 A-type potassium channel via direct phosphorylation of the pore-forming alpha subunit at the three sites previously mapped. We used a site-directed mutagenesis approach to determine if mimicking phosphorylation of Kv4.2 at these sites alters channel functional properties, biophysical characteristics, and cell-surface expression. 5 Overall, our results support the hypothesis that ERK regulates Kv4.2 channels by direct phosphorylation. Our mutagenesis and functional studies indicate that introduction of a negative charge at serine 607 in the C-terminus of Kv4.2 affects the voltage-dependence of channel activation and the rate of recovery from inactivation. These effects are reminiscent of the effects of ERK activation on A-current in intact neurons. This regulation of the outward K + current is due to changes in gating kinetics of the current as ERK phosphorylation has no effect on protein expression or surface membrane localization. These results provide a bridge between prior biochemical results obtained in vitro (1) and functional studies performed in the dendrites of neurons and indicate that direct ERK phosphorylation of Kv4.2 channel is a primary mechanism for the ERK-mediated decrease in A-type currents previously reported (21, 22, 47, 51) .
METHODS

Functional expression in Xenopus oocytes
Oocytes were harvested as described previously (33 subtracted on line using P/4 leak subtraction. Data was digitized at 2 kHz and stored to 6 computer using a Digidata 1200. Current protocols used to obtain data include: 1) activation -hyperpolarization to -110 mV then depolarization to +40 mV for 400-800 msec and repeated in -5 or -10 mV step intervals. 2) Inactivation -depolarization to 0 mV then hyperpolarization to -110 mV for 650 msec, changing this step by +5mV intervals, then depolarization to 0 mV. 3) Recovery from inactivation for oocytes expressing Kv4.2 alone a two pulse protocol was used, which included a 500 ms depolarization to 0 mV followed by a hyperpolarization to -110 mV of varying durations (5 msec with subsequently longer hyperpolarizations increasing in increments of 100 ms) for a final hyperpolarization of 705 msec, then depolarized to 0 mV. Kv4.2+KChIP3 recovered from inactivation more quickly than Kv4.2 alone, so the initial hyperpolarization pulse was 2 milliseconds increasing in increments of 10 milliseconds for a final duration of hyperpolarization of 192 milliseconds.
The chamber was continuously perfused at a rate of 3-6 ml/min with ND-96 (in mM):
96 NaCl; 2 KCl; 1.8 CaCl 2 ; 1 MgCl 2 ; and 5 HEPES pH 7.4 with NaOH. Oocytes expressing mutant DNA and wildtype (control) DNA were always recorded on the same day, and were recorded in at least 3 batches of ooctyes. The data from oocytes expressing wildtype DNA from different days were not different, therefore all wildtype data was combined. Data was analyzed using Clampfit, Origin, and Prism programs. Inactivation time constants were fit in Clampex with the Simplex method. Peak currents were obtained and conductance was determined using a reversal potential (V rev ) of -95 mV according to the equation, G = I p /(V c -V rev ). Where I p is the peak of the current at a given voltage command (V c ). Activation and inactivation curves were fit with Boltzman sigmoidal curve with the equation of G/G max = 1/{1+exp (X-V 1/2 )/Slope)}. Where X is equal to the test potential (V m ). The mean ± SEM V 1/2 (voltage at which half the currents are activated) was determined from the Boltzman fit 7 and compared among the mutants and WT using a One-Way Anova and post-hoc Bonferroni test.
DNA preparation and Site-directed Mutagenesis
The original Kv4.2 and KChIP3 cDNA were provided by Dr. Paul Pfaffinger. Both constructs are in a CMV vector. Point mutations were made using the site-directed mutagenesis kit (Stratagene). The primers (upper sequence) used include T602A-5'-
Mutations were confirmed by restriction enzyme digest and DNA sequencing. In most cases, the entire Kv4.2 region was sequenced to ensure that no other mutations existed.
Expression in COS-7 cells
The 
Protein expression and purification
The WT and AAA Kv4.2 C-terminal proteins were expressed in E. coli as glutathione Stransferase (GST) fusion proteins using methods modified from Hakes and Dixon (20) .
Plasmids containing the Kv4.2 C-terminal cDNAs were constructed using the GST-fusion The cells were resuspended and incubated in Tris buffer 1 (50mM Tris-HCl, pH 8.0, 2mM EDTA, 10 mg/ml pepstatin, 10 µg/ml leupeptin, 100 µM PMSF) containing 10 mM β-mercaptoethanol and 100 µg/ml of lysozyme (Sigma) for 15 min at 30°C. Following solubilization with 1.5% N-laurylsarcosine, the lysate is incubated with 20 µg/ml Dnase I (Boehringer Mannheim) and 10 mM MgCl 2 . The lysate is then centrifuged (Sorvall RT 6000B, 1000 g, 15 min, 4°C) and adjusted to a 2% Triton X-100 concentration.
The GST-fusion proteins were purified using glutathione affinity absorption. Glutathione agarose beads were washed, resuspended in Tris buffer 1, and then incubated with the lysate for 1 hr at 4°C. The beads were washed 3 times with Tris buffer 1 by repeated centrifugation (Sorvall, 100 g, 5 min, 4°C). After the final wash, the bead preparation was resuspended in
Tris buffer 2 (20 mM Tris-HCl, pH 7.5, 0.5 mM EDTA, 0.5 mM EGTA, 1 mM Na 4 P 2 O 7 , 10 µg/ml aprotinin, 10 µg/ml leupeptin.
Protein phosphorylation
WT and AAA GST fusion proteins were phosphorylated with activated ERK2 for 0.5-1 hour at 37ºC according to the manufacturers' directions (Stratagene). The reaction included:
1.0µCi/µl reaction of [ -32 P]ATP in the presence of activated ERK2, HEPES buffer (in mM:
25 HEPES, 0.5 EDTA, 0.5 EGTA, 1 Na 4 P 2 O 7 , 10 µg/ml aprotinin, 10 µg/ml leupeptin), 10 mM MgCl 2 , and 100 µM ATP. The reaction was stopped with sample buffer [in mM: 30
Tris-HCl, pH 6.8, 200 dithiothreitol, 40% glycerol, 8% sodium dodecyl sulfate (SDS), 0.04 mg/ml bromophenol blue], and the samples were boiled for 5 min. The fusion proteins were separated using 10% SDS-polyacrylamide gel electrophoresis and visualized by Coomassie
Blue staining. The phosphopeptides were identified by autoradiography.
RESULTS
We previously identified three candidate ERK phosphorylation sites in the C-terminal domain of Kv4.2 through in vitro studies ( Figure 1 ) (1). Two other ERK consensus sequences exist within the Kv4.2 C-terminal sequence, but these sites were not phosphorylated in our initial studies. We have also developed a phospho-specific antibody that recognizes full-length Kv4.2 when it is phosphorylated at all three ERK phosphorylation sites (1) . Using this affinity-purified antiserum we observed that basal levels of phosphorylation of Kv4.2 exist in mouse hippocampal tissue ( Figure 1C ) and COS-7 cells ( Figure 1D ), confirming that these sites are indeed sites of phosphorylation in the intact Kv4.2 channel in both COS-7 cells and hippocampus.
Given an ERK-mediated decrease in the A-type current in hippocampal slices (47, The co-expression of Kv4.2 + KChIP3 in expression systems such as oocytes and COS-7 cells better approximates the functional properties of the native channels (2, 24, 31, 33) .
Mutation of all three sites to aspartate mimics the effect seen in neurons
In our first experiment we tested the effects of mimicking ERK phosphorylation of (Table 1) . While there was a trend toward a slower rate of recovery from inactivation for the triple D mutant, it was not significantly different from wildtype (Table 1) .
To investigate the contribution of each individual phosphorylation site to the regulation of the transient outward K + current, we investigated the functional consequences of single aspartate mutants to mimic ERK phosphorylation at each individual phosphorylation site.
We first investigated the effects of mutation of S616 to an aspartate.
Mutation of serine 616 to aspartate does not mimic the effect seen in neurons
Surprisingly, mutation of the S616 site to aspartate caused an effect contrary to the effect of the triple D mutant. Mutation of S616D shifted the activation voltage to more hyperpolarized voltages compared to WT ( Figure 3B ). The activation curve of the S616D mutant was shifted 11 mV to the left toward more hyperpolarized membrane potentials. The mean V 1/2 for the S616D mutant was -35 ± 2 mV, compared to WT (-24 ± 3 mV).
Interestingly, the effect of the S616D mutant is opposite the effect of ERK on A-currents in hippocampal dendrites. This finding suggests that phosphorylation at this site does not mediate the effects of ERK on A-currents in the dendrites of hippocampal pyramidal neurons. The data with the 616D mutant suggest that phosphorylation at T602 and T607, the remaining two sites, might cause an effect similar to that seen in response to ERK activation in the dendritic A-current in intact cells and similar to the triple D site mutants as well. We therefore determined if mutation of both T602 and T607 to D caused channel inhibition as we anticipated based on neuronal recordings of A-currents and the effect of the Triple D mutant in the oocyte expression system.
Threonine 602D,607D mimics the effect seen in neurons
Consistent with this idea, the T602D,T607D double mutant channel exhibited a shift in the voltage-dependence of activation to more depolarized potentials. The T602D,T607D double mutant showed a 14 mV shift in the voltage-dependence of activation ( Figure 3B ).
The mean V 1/2 of the T602D,T607D mutant (-10 ± 2 mV) was significantly different (p<0.01) from WT (-24 ± 3 mV). The double mutant also displayed a slower recovery from inactivation (19 ± 5, n = 6) that was significantly different than wildtype (Table 1 ; p<0.05).
Similar to the triple D mutation, the inactivation was fit with a single exponential and determined that the time constant of inactivation of the T602D,T607D mutant (29 ± 6 ms) was significantly different from WT (57 ± 5 ms; p<0.01).
The T602D,T607D double mutant channel was quantitatively similar to the triple D mutant channel as the values for V 1/2 and recovery from inactivation were not significantly different from the triple D (p>0.05). This suggests that the effects of the aspartate mutation at T602 and T607 are responsible for the channel inhibition that we observed in the triple D mutant channel.
Overall our data suggest that there are different effects of phosphorylation of Kv4.2 by ERK at the S616 site versus the T602 and T607 sites. Mutation of T602 and T607 to an aspartate has an overall effect of less current (shift of activation and slower recovery from inactivation), whereas the effect of the aspartate mutation at 616 has the opposite effect, with insertion of a negative charge causing more current and faster recovery from inactivation. It is important to note that the phosphorylation of T602 and T607 mimic the effect of ERK activation on the dendritic A-current in intact cells. Moreover, taken together our data suggest that if all three sites are phosphorylated (mimicked in the triple D mutant), the inhibitory influence dominates over the potentiating effect. That is, we predict that in the native channels, the 602/607 site effect will predominate over the S616 effect if all the sites are phosphorylated simultaneously.
Mutation of threonine 602 to aspartate has no effect
We next sought to determine the effects of mutation of the 602 and 607 sites individually. Mutation of T602 alone to an aspartate (T602D) or to an alanine (T602A) had no significant effect on Kv4.2 current (data not shown). There was no apparent shift in activation voltage of Kv4.2 current, steady-state inactivation, or recovery from inactivation (Table 1 ). These data suggest that modification of the 602 site is not sufficient to mimic dual modification of the 602 plus 607 sites.
Mutation of threonine 607 to aspartate mimics the effect in neurons
In contrast, mutation of T607 to aspartate caused a pronounced shift toward depolarized potentials in the voltage-dependence of activation of Kv4.2 currents. Thus, mimicking phosphorylation of T607 causes the current to activate at more depolarized potentials ( Figure   3A ,B). The mutation of T607 to alanine is an important control that suggests that any mutation of this site does not simply cause a conformational change in the protein structure.
The activation curve of the T607D mutant also showed an 18 mV shift (-6 ± 3 mV, n = 12) toward more depolarized membrane potentials that was significantly different compared to WT (p<0.001; -24 ± 3 mV) and T607A (p<0. Mutation of T607 to an aspartate has a similar effect on the outward K + current as both the triple D mutation and the T602D,T607D double mutation. Specifically, the V 1/2 and the recovery from inactivation of the T607D mutant channel were not significantly different from the triple D or the double mutant channel. Importantly, these changes are similar to the effects of ERK activation on the A-type current in hippocampal dendrites. A parsimonious interpretation of our data is that ERK phosphorylation of T607 in vivo is a mechanism by which ERK inhibits A-currents formed by Kv4.2 in neurons. This is suggested by the shift of the activation voltage of the T607D mutant to more depolarized potentials and the decrease in the rate of recovery from inactivation in the T602D and T607D mutants. As we also observed a decrease in the rate of recovery from inactivation in the T602D mutant, phosphorylation of this site may also contribute to channel inhibition as well.
T607D Effect Requires KChIP Coexpression
We have previously reported that the functional effects of PKA phosphorylation of (Table 1) . Interestingly, while expression of KChIP3 with the WT and T607A channels causes a leftward shift in the activation voltage, only a small shift of the activation voltage is revealed with the T607D mutation ( Figure 5 ).
In addition no effect was seen on the rate of recovery from inactivation for either mutation (Table 1) . Therefore it appears that coexpression of KChIP3 is necessary for the functional effects of ERK phosphorylation at the C-terminal ERK phosphorylation site (T607 One caveat to the interpretation of our results is that there are two other minimal ERK consensus sites (simply a serine or threonine followed by a proline) in the C-terminal of Kv4.2, at S516 and T567. While these sites could potentially be phosphorylated by ERK, we did not observe any phosphorylation of these sites in our initial characterization of ERK phosphorylation of the Kv4.2 C-terminus (Adams et al 2000) . Therefore, it is unlikely that they are phosphorylated in the full-length protein.
In an additional control experiment (data not shown), we made a GST-fusion protein construct of the WT C-terminal and triple A mutant C-terminal (T602A, T607A, S616A) and performed an in vitro phosphorylation with activated ERK. As expected the WT C-terminal fusion protein was phosphorylated by ERK/MAPK. Phosphorylation of the triple A mutant C-terminal was greatly reduced (24 ± 5% of control; n=6), normalized to protein concentration) suggesting that blocking phosphorylation at the T602, T607 and S616 sites greatly reduces ERK phosphorylation of the C-terminal. These data thereby serve as an independent confirmation of our previous direct sequencing studies and indicate using the site-directed mutagenesis approach that these sites are indeed phosphorylated by ERK/MAPK. The residual amount of phosphorylation suggests that the S516 or T567 sites may be phosphorylated in vitro. However, we also cannot rule out the possibility that mutation of the three sites to alanine may alter protein structure and reveal a previously unphosphorylated site.
Protein expression and surface localization
Finally, to determine whether ERK phosphorylation alters protein expression and/or channel surface localization, we expressed the ERK site mutants in the COS-7 cell expression system. This heterologous expression system is more suitable for these studies as levels of protein expression can be highly variable in oocytes. Moreover, we have previously observed phosphorylation-dependent and KChIP-dependent alterations in channel trafficking in COS cells (38, 45). We found no statistically significant effect on total protein expression of any of the site mutants ( Table 1) . As COS-7 cells have significant basal ERK activity and Kv4.2 phosphorylation (see Figure 1 ), these data suggest that ERK phosphorylation of Kv4.2 is not a major determinant of overall Kv4.2 channel expression in these cells.
We also found no significant effect of phosphorylation of the Kv4.2 channel on surface expression ( Figure 6C) Figure 1C ). Finally, that these candidate ERK sites are capable of being phosphorylated in the intact channel in vivo ( Figure 1C and (1)). The present studies provide a direct bridge from these earlier in vitro studies to functional studies in the intact cell. Based on our findings, we hypothesize that ERK modulates the A-type current by direct regulation of the Kv4.2 alpha subunit. Our findings support this hypothesis by demonstrating that mimicking ERK phosphorylation of the Kv4.2 alpha subunit is capable of regulating channel biophysical and functional
properties. Specifically, we found that mimicking phosphorylation of T607 significantly decreases the current.
Interestingly, the three ERK phosphorylation sites do not appear to have a universal effect. Specifically, introduction of a negative charge at the S616 site causes an effect opposite to that of the T602 and T607 sites. The S616D mutation causes a leftward shift of the activation curve and a faster recovery from inactivation, while the S616A mutation slows recovery from inactivation. This effect of the alanine mutation at S616 has 2 possible explanations: 1) mutation of S616 causes structural changes that affect the Kv4.2 currentspecifically altering inactivation kinetics (see below); or 2) S616, and not T602 or T607, is endogenously phosphorylated in the oocyte, and the S616A mutant blocks this effect.
Considering the first possible explanation, a structural change in the protein could have results unrelated to phosphorylation at the S616 residue, thus causing an effect independent of phosphorylation. In the second explanation, endogenous phosphorylation in the oocyte could be the result of phosphorylation by ERK or another MAPK. Indeed, activation of ERK vs other MAPKs has been shown to have antagonistic effects (reviewed in (10, 28) ).
Finally, while we did not find an effect on surface expression with our mutants in COS cells, we cannot rule out that these sites may participate in targeting the Kv4 subunits to subcellular domains within a specific cell type.
Mechanism of effects
The functional changes that occur upon direct ERK phosphorylation of Kv4.2 appear to be dependent upon its interaction with KChIP. For example, we saw no effect on channel properties with mutation of T607 to an aspartate or to an alanine in the absence of KChIP. In addition, we observed an effect of mimicking ERK phosphorylation on the activation voltage as well as recovery from inactivation, two kinetic characteristics that have been shown to be modified by KChIP interaction (4, 5, 16) . This suggests that KChIP coexpression is necessary for functional effects as we and others have previously observed for other phosphorylation sites or other biophysical modulation (24, 33). We cannot rule out the possibility that interactions with other accessory subunits, such as the dipeptidyl peptidaselike proteins (26, 27 ) may also play an important role in the regulation of the current by phosphorylation.
Functional implications
The present studies implicate the Kv4.2 voltage-dependent potassium channel as a direct target of ERK. In the context of neuronal development and differentiation as well as disease processes, direct ERK/MAPK phosphorylation of Kv4 channel subunits presents a possible mechanism for the acute regulation of K + currents by growth factors as has been previously reported (12, 49).
In addition, we and others recently have implicated MAPKs in long-term neuronal plasticity and memory formation, and have hypothesized that MAPKs regulate voltagedependent ion channels in neurons as part of a coordinated mechanism for triggering lasting change in neurons. Previous studies have shown that the dendritic A-current is modulated by 23 ERK activation (21, 22, 47, 51) . Moreover, in an animal model of temporal lobe epilepsy, dendritic A-type currents are reduced along with Kv4.2 protein as well as mRNA.
Interestingly, an increase in ERK phosphorylation of the remaining Kv4.2 channels is observed, and kinase inhibition can partially reverse the hyperexcitable effects of decreased A-current (7) 
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